amplifyeP24 Awarded a U.S. Patent for Blood Sugar Regulation

In 2024, amplifyeP24 was issued a U.S. patent recognizing its ability to help reduce post-meal blood-sugar spikes through the science of protein digestion and absorption.

The patent covers a method in which protein (specifically legumes) paired with enzymes from the S53 family helped maintain steady blood-glucose levels despite the presence of glucose. P24 belongs to this family of enzymes and was the enzyme used in the experiment that earned this patent. 

Why It Matters

This milestone validates years of research connecting protein absorption to metabolic health. When protein is broken down more efficiently, amino acids are released earlier in digestion, signaling the body to manage glucose and insulin more effectively.

The result:

• More stable blood-glucose levels

• Fewer post-meal energy crashes

• Improved nutrient utilization

The Science Behind the Patent

The link between protein intake and blood-glucose control is well established. Scientific studies have shown that adding high-quality protein to meals can naturally improve the body’s glucose response by:

• Stimulating insulin and glucagon release: Amino acids “prime” pancreatic cells to manage glucose more efficiently.

• Enhancing glucose uptake by cells: Amino acids like leucine help improve the way cells use glucose for energy.

• Slowing gastric emptying: Protein slows the rate of digestion, promoting a steadier release of glucose into the bloodstream.
  
  

This mechanism aligns with P24’s unique ability to improve how the body processes protein, turning a meal’s nutrients into more effective metabolic signals.

Informing Future Research

The issuance of this patent has encouraged amplifyep24’s co-founding scientists to continue studying the connection between protein enzymes and post-meal glucose response.

Early pilot studies provided strong evidence to secure the patent, and new research is underway to better understand how optimizing protein absorption can support long-term metabolic health.

The patent applies broadly to the S53 family of proteases, which includes more than 13,000 possible enzymes. P24 is one of them and one of the first to demonstrate measurable effects on both protein bioavailability and blood-glucose regulation.

Building on Established Science

Protein’s influence on glucose metabolism has been observed across numerous human and in-vitro studies:

1. Nutrients (2019): “Impact of Dietary Protein on Postprandial Glycaemic Control and Insulin Requirements: A Systematic Review.”

2. Nutrients (2023): “Effect of a High-Protein Diet at Breakfast on Postprandial Glucose Level.”

3. Frontiers in Nutrition (2024): “Pre-Meal Whey Protein Lowers Postprandial Blood Glucose in Healthy Women.”

4. Journal of Nutrition (2024): “Adding Protein to a Carbohydrate Meal Reduces Postprandial Glycemia.”

5. Frontiers in Nutrition (2021): “Dietary Proteins Decrease Intestinal Glucose Uptake and Improve Glucose Tolerance.”
   
   

Together, these findings reinforce a growing body of evidence:

Optimizing protein absorption can improve glucose balance, energy stability, and overall metabolic health.

Looking Ahead

This patent represents more than a scientific milestone—it’s a step toward redefining how we think about nutrition. By improving protein absorption, we can improve how the body processes and responds to what we eat, turning every meal into an opportunity for better health.

P24 is the enzyme helping make that possible.